PTSDgene database

GO Report

Basic Info
ID GO:0005886
Name plasma membrane
Type cellular component
No. of Genes in PTSDgene  99

GO related genes in PTSDgene (count: 99)
Approved Symbol Approved Name Location Type No. of Association Studies (Positive/Negative/Trend) Evidence[PMID]
GRIN2A glutamate receptor, ionotropic, N-methyl D-aspartate 2A 16p13.2 Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy 1(0/1/0) TAS
TAB2 TGF-beta activated kinase 1/MAP3K7 binding protein 2 6q25.1 rSNP target 0 TAS
CHRNB4 cholinergic receptor, nicotinic beta 4 15q24 Mapped by Literature SNP, Mapped by LD-proxy, rSNP target 0 TAS
CHRNB3 cholinergic receptor, nicotinic beta 3 8p11.21 Mapped by Literature SNP, Mapped by LD-proxy 0 TAS
APOB apolipoprotein B 2p24-p23 Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy 1(0/0/1) IDA; TAS
UAP1 UDP-N-acetylglucosamine pyrophosphorylase 1 1q23.2 rSNP target 0 IDA
CLTC clathrin heavy chain 17q23.1 rSNP target 0 TAS
CHRNA7 cholinergic receptor, nicotinic alpha 7 15q13.3 Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy 1(1/0/0) IDA[12508119|16280133|21718690]; TAS
CHRNA6 cholinergic receptor, nicotinic alpha 6 8p22 Literature-origin, Mapped by Literature SNP 1(0/1/0) TAS
OXTR oxytocin receptor 3p25 Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy 2(0/2/0) TAS
UNC13C unc-13 homolog C (C. elegans) 15q21.3 Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy 1(0/0/1) ISS
RGS7 regulator of G-protein signaling 7 1q43 Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy 1(0/0/1) IBA
CHRNA5 cholinergic receptor, nicotinic alpha 5 15q24 Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy, rSNP target 2(1/1/0) TAS
NTM neurotrimin 11q25 Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy 1(0/0/1) IEA
CAV3 caveolin 3 3p25 Mapped by Literature SNP, Mapped by LD-proxy 0 IDA[17060380|20472890]; TAS
LTA lymphotoxin alpha 6p21.3 Mapped by Literature SNP 0 TAS
MYLIP myosin regulatory light chain interacting protein 6p22.3 rSNP target 0 IEA
CHRNA3 cholinergic receptor, nicotinic alpha 3 15q24 Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy, rSNP target 1(0/1/0) TAS
HLA-F major histocompatibility complex, class I, F 6p21.3 rSNP target 0 IBA; TAS
GABRG3 gamma-aminobutyric acid (GABA) A receptor, gamma 3 15q12 Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy 1(0/1/0) TAS
TSPAN1 tetraspanin 1 1p33 rSNP target 0 IDA[21836059]
VIPR1 vasoactive intestinal peptide receptor 1 3p22 rSNP target 0 TAS
ADRB2 adrenoceptor beta 2 5q31-q32 Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy 1(0/1/0) IDA[9235896]; TAS
AKT3 v-akt murine thymoma viral oncogene homolog 3 1q44 Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy 1(0/0/1) IDA
ZNRF2 zinc and ring finger 2, E3 ubiquitin protein ligase 7p15.1 rSNP target 0 IDA[22797923]
NCAM1 neural cell adhesion molecule 1 11q23.2 Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy 1(0/1/0) IDA; TAS
CHRNA4 cholinergic receptor, nicotinic alpha 4 20q13.33 Literature-origin 1(1/0/0) ISS; TAS
GABBR2 gamma-aminobutyric acid (GABA) B receptor, 2 9q22.1-q22.3 Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy 1(0/0/1) TAS
DRD3 dopamine receptor D3 3q13.3 Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy 2(1/1/0) IDA[16386234|18424554|20531939]; TAS
OR11L1 olfactory receptor family 11 subfamily L member 1 1q44 Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy 1(0/0/1) TAS
CACNA1C calcium channel, voltage-dependent, L type, alpha 1C subunit 12p13.3 Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy 2(0/2/0) IDA[11206130]; TAS
SLC6A3 solute carrier family 6 (neurotransmitter transporter), member 3 5p15.3 Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy 21(11/10/0) IDA[11343649|12958153]; TAS
GRIN1 glutamate receptor, ionotropic, N-methyl D-aspartate 1 9q34.3 Literature-origin 1(0/0/1) TAS
GABRA2 gamma-aminobutyric acid (GABA) A receptor, alpha 2 4p12 Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy 3(1/2/0) TAS
ADCYAP1R1 adenylate cyclase activating polypeptide 1 (pituitary) receptor type I 7p14.3 Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy 19(8/11/0) TAS
PIK3C2A phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 alpha 11p15.5-p14 rSNP target 0 IDA[21081650]
PRKCA protein kinase C, alpha 17q24.2 Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy 10(9/0/1) IDA[15632189|23990668]; TAS
OPRL1 opiate receptor-like 1 20q13.33 Literature-origin, Mapped by Literature SNP 0 TAS
GJD2 gap junction protein delta 2 15q13.1 rSNP target 0 TAS
DEF6 DEF6, guanine nucleotide exchange factor 6p21.33-p21.1 rSNP target 0 IEA
DRD4 dopamine receptor D4 11p15.5 Literature-origin, Mapped by Literature SNP 7(2/5/0) IDA[20531939]; TAS
KCNC1 potassium channel, voltage gated Shaw related subfamily C, member 1 11p15 rSNP target 0 TAS
FASLG Fas ligand 1q23 Literature-origin 1(0/0/1) IDA[12201652]
NDRG1 N-myc downstream regulated 1 8q24 Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy 1(0/0/1) IDA[12432451]
APOA1 apolipoprotein A-I 11q23-q24 Mapped by LD-proxy 0 TAS
TRAF7 TNF receptor associated factor 7 16p13.3 rSNP target 0 IDA
TRPA1 transient receptor potential cation channel, subfamily A, member 1 8q13 rSNP target 0 TAS
DPP6 dipeptidyl-peptidase 6 7q36.2 Literature-origin, Mapped by Literature SNP 1(0/0/1) ISS
LIN7C lin-7 homolog C (C. elegans) 11p14 rSNP target 0 IDA[23201090]; TAS
COMT catechol-O-methyltransferase 22q11.21 Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy 21(9/12/0) TAS
GHRHR growth hormone releasing hormone receptor 7p14 rSNP target 0 IDA[10461027]; TAS
PLXNC1 plexin C1 12q23 Literature-origin 1(0/0/1) TAS
PTPRT protein tyrosine phosphatase, receptor type T 20q12-q13 Literature-origin, Mapped by Literature SNP 1(0/0/1) IDA[18644975]
TNF tumor necrosis factor 6p21.3 Mapped by Literature SNP 1(1/0/0) TAS
TULP1 tubby like protein 1 6p21.3 Mapped by LD-proxy 0 IDA[16303976]
ANK3 ankyrin 3, node of Ranvier (ankyrin G) 10q21 Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy 2(2/0/0) ISS
LGR6 leucine-rich repeat containing G protein-coupled receptor 6 1q32.1 Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy 1(0/0/1) TAS
CLIC1 chloride intracellular channel 1 6p21.3 rSNP target 0 IEA
MICB MHC class I polypeptide-related sequence B 6p21.3 rSNP target 0 IBA; TAS
SLC4A5 solute carrier family 4 (sodium bicarbonate cotransporter), member 5 2p13.1 Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy 1(0/0/1) TAS
NUCB2 nucleobindin 2 11p15.1 rSNP target 0 TAS[7811391]
PARD6B par-6 family cell polarity regulator beta 20q13.13 rSNP target 0 IDA[12545177]; TAS
ITGA6 integrin subunit alpha 6 2q31.1 Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy 1(0/1/0) IDA[21310825]; TAS
MAPT microtubule associated protein tau 17q21 Mapped by LD-proxy, rSNP target 0 IDA[8522593]
SDC2 syndecan 2 8q22-q23 Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy 1(0/0/1) TAS
OR2L13 olfactory receptor family 2 subfamily L member 13 1q44 Literature-origin 1(0/0/1) TAS
LTB lymphotoxin beta 6p21.3 rSNP target 0 TAS
ARHGAP21 Rho GTPase activating protein 21 10p12.31 rSNP target 0 IEA
ABCC1 ATP binding cassette subfamily C member 1 16p13.1 Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy 1(0/0/1) IDA; TAS
CRHR1 corticotropin releasing hormone receptor 1 17q21.31 Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy, rSNP target 12(6/6/0) TAS
CHRNA2 cholinergic receptor, nicotinic alpha 2 8p21 Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy, rSNP target 1(1/0/0) TAS
ARVCF armadillo repeat gene deleted in velocardiofacial syndrome 22q11.21 Mapped by Literature SNP, Mapped by LD-proxy 0 IEA
LRPAP1 LDL receptor related protein associated protein 1 4p16.3 Literature-origin 1(0/0/1) IDA[16263759]
ADCY8 adenylate cyclase 8 (brain) 8q24 Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy 1(0/0/1) TAS
SLC20A2 solute carrier family 20 (phosphate transporter), member 2 8p11.21 rSNP target 0 TAS
C8orf37 chromosome 8 open reading frame 37 8q22.1 Literature-origin 1(0/0/1) IDA
RGS2 regulator of G-protein signaling 2 1q31 Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy, rSNP target 7(2/5/0) IBA; IDA[11278586]
VASP vasodilator-stimulated phosphoprotein 19q13.32 Mapped by Literature SNP 0 IDA
HTR1A 5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled 5q12.3 Literature-origin, Mapped by Literature SNP 1(0/1/0) TAS
PAQR7 progestin and adipoQ receptor family member VII 1p35.3 Mapped by LD-proxy, rSNP target 0 IBA
SLC6A4 solute carrier family 6 (neurotransmitter transporter), member 4 17q11.2 Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy, rSNP target 44(13/31/0) IDA[16870614|17506858|18227069|19270731]
GRIN2B glutamate receptor, ionotropic, N-methyl D-aspartate 2B 12p13.1 Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy 1(0/1/0) TAS
SLC6A2 solute carrier family 6 (neurotransmitter transporter), member 2 16q12.2 Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy 13(4/9/0) TAS
SLC18A2 solute carrier family 18 (vesicular monoamine transporter), member 2 10q25 Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy 3(2/1/0) TAS
APOE apolipoprotein E 19q13.31 Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy, rSNP target 6(2/4/0) TAS
HLA-G major histocompatibility complex, class I, G 6p21.3 Mapped by LD-proxy 0 IBA; TAS
DRD2 dopamine receptor D2 11q23.2 Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy 18(11/7/0) TAS
GML glycosylphosphatidylinositol anchored molecule like 8q24.3 Mapped by Literature SNP 0 IEA
RAB5A RAB5A, member RAS oncogene family 3p24.3 rSNP target 0 IBA
NLGN1 neuroligin 1 3q26.32 Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy 1(1/0/0) ISS
CAT catalase 11p13 Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy, rSNP target 1(1/0/0) IEA
HTR2A 5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled 13q14-q21 Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy 4(2/2/0) IDA[15862800|18703043]; TAS
CNR1 cannabinoid receptor 1 (brain) 6q14-q15 Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy 2(0/2/0) TAS
IL2RA interleukin 2 receptor subunit alpha 10p15-p14 Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy 1(1/0/0) TAS
COBL cordon-bleu WH2 repeat protein 7p12.2-p12.1 Literature-origin 2(1/1/0) ISS
PRKG1 protein kinase, cGMP-dependent, type I 10q11.2 Literature-origin, Mapped by Literature SNP 1(0/0/1) IDA[16990611|21402151]
ARRB1 arrestin, beta 1 11q13 Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy 1(0/1/0) TAS[9924018]
CRHR2 corticotropin releasing hormone receptor 2 7p14.3 Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy 2(2/0/0) TAS
VMP1 vacuole membrane protein 1 17q23.1 rSNP target 0 IEA